South Carolina Magazine

Fine Treatment Reveals Benign Prostatic Hyperplasia & Chronic Prostatitis Drugs vs Thermobalancing Therapy

 Breaking News
  • No posts were found

Fine Treatment Reveals Benign Prostatic Hyperplasia & Chronic Prostatitis Drugs vs Thermobalancing Therapy

December 27
14:10 2018

It was estimated that about 14 million men in the United States are diagnosed with lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH). This problem affects 50% of men aged before their 60th, and this percentage increases to 90% by the age of 80. Many middle age men suffer from chronic prostatitis.

LUTS or urinary symptoms caused by enlarged prostate are: frequent or urgent need to urinate, increased frequency of urination at night (nocturia), difficulty starting urination, weak or dribbling urine stream. The main symptom of chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS) is pain. It should be noted that, despite the fact that these symptoms are unpleasant, BPH and CP/CPPS are not a life-threatening conditions, and these problems should be treated without harming the health of men.

Therefore, Thermobalancing therapy and non-invasive Dr Allen’s Device should be the first line treatment when prostate enlargement or inflammation is diagnosed. This is a completely new therapy, which received a U.S. patent, as Therapeutic device and method.

Today, the standard starting treatment of BPH or chronic prostatitis are medications. Unfortunately, they do not treat an affected prostate gland but trying to provide urination symptoms relief. Furthermore, BPH drugs are risky and can cause serious side effects.

BPH drugs are risky. In August and September 2018 have been published scientific articles about Post-finasteride Syndrome (PFS) exploring that the medical community has an obligation not to turn a blind eye on this debilitating condition. 5-alpha-reductase inhibitors, finasteride and dutasteride, Avodart and Proscar should be prescribed to men with BPH and CP/CPPS with great caution due to their irreversible side effects.

These articles, namely, “The Post-finasteride Syndrome: Clinical Manifestation of Drug-Induced Epigenetics Due to Endocrine Disruption” and “Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin?” indicate development serious sexual dysfunction and depression after BPH drugs. Moreover these medications do not treat the affected prostate gland but try to provide the symptoms relief.

Contrary to them, Thermobalancing therapy with Dr Allen’s Device improves blood circulation in the prostate tissue influencing the underlying cause of enlarged prostate and CP/CPPS. 2 clinical trials have shown dramatically reduce of pain and LUTS, and improvement quality of life in men with BPH and CP/CPPS. No adverse side effects were found. Thus, Thermobalancing therapy and Dr Allen’s Device is the safe treatment option for a prostate gland, helping men recover from BPH and CP/CPPS without adverse events.

The therapy and device has received a U.S. patent, as Therapeutic device and method. Dr Allen’s Device, which applies thermoelement tightly to the skin, is a class 1 medical device, which does not require the involvement of a notified body at any country. So, everyone can use this device at home without worrying, as this treatment option causes no side effects. Fine Treatment delivers Dr. Allen’s Device by guaranteed by Royal mail and USPS tracking services worldwide.

Media Contact
Company Name: Fine Treatment
Contact Person: Dr Simon Allen, MD, PhD, Director – Fine Treatment
Email: Send Email
Phone: +447958878300
Country: United Kingdom
Website: https://finetreatment.com